Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Q32 Bio (QTTB) Total Current Liabilities (2017 - 2025)

Q32 Bio (QTTB) has 9 years of Total Current Liabilities data on record, last reported at $11.3 million in Q4 2025.

  • For Q4 2025, Total Current Liabilities fell 31.09% year-over-year to $11.3 million; the TTM value through Dec 2025 reached $11.3 million, down 31.09%, while the annual FY2025 figure was $11.3 million, 31.09% down from the prior year.
  • Total Current Liabilities reached $11.3 million in Q4 2025 per QTTB's latest filing, up from $11.1 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $33.0 million in Q1 2024 and bottomed at $11.1 million in Q3 2025.
  • Average Total Current Liabilities over 5 years is $18.7 million, with a median of $18.2 million recorded in 2021.
  • Peak YoY movement for Total Current Liabilities: soared 78.06% in 2024, then tumbled 55.76% in 2025.
  • A 5-year view of Total Current Liabilities shows it stood at $17.2 million in 2021, then soared by 31.06% to $22.6 million in 2022, then tumbled by 37.5% to $14.1 million in 2023, then grew by 16.7% to $16.5 million in 2024, then crashed by 31.09% to $11.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for Total Current Liabilities were $11.3 million in Q4 2025, $11.1 million in Q3 2025, and $11.5 million in Q2 2025.